Yang Xu

7PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 21, 2024
CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial.

Yang Xu, Xuzhao Zhang, Dijia Xin

|Feb 05, 2024
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study.

Fangshu Guan, Luxin Yang, Yi Chen

|May 19, 2023
Increased Expression of SRSF1 Predicts Poor Prognosis in Multiple Myeloma.

Jiawei Zhang, Zanzan Wang, Kailai Wang

|Jun 01, 2022
Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials.

Yang Xu, Ping Li, Yang Liu

|May 20, 2022
Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cells.

Jiawei Zhang, Yichao Gan, Hongzhi Li

|Jan 09, 2021
Post-transplant cyclophosphamide versus antithymocyte globulin in allogeneic hematopoietic cell transplantation: a meta-analysis.

Feiqiong Gao, Jiawei Zhang, Jianlai Hu

Pageof 2

Frequent Collaborators

2 joint publications

Wenbin Qian

2 joint publications

Jiawei Zhang

2 joint publications

Xi Qiu

1 joint publications

Jie Yin